238 related articles for article (PubMed ID: 17560055)
41. The improvement of ibuprofen dissolution rate through microparticles spray drying processed in an aqueous system.
Wikarsa S; Durand D; Delarbre JL; Baylac G; Bataille B
Drug Dev Ind Pharm; 2008 May; 34(5):485-91. PubMed ID: 18473230
[TBL] [Abstract][Full Text] [Related]
42. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
43. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
44. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
45. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
46. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
47. Rational Design and Characterization of a Nanosuspension for Intraoral Administration Considering Physiological Conditions.
Baumgartner R; Teubl BJ; Tetyczka C; Roblegg E
J Pharm Sci; 2016 Jan; 105(1):257-67. PubMed ID: 26852857
[TBL] [Abstract][Full Text] [Related]
48. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
[TBL] [Abstract][Full Text] [Related]
49. Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.
Singhal M; Baumgartner A; Turunen E; van Veen B; Hirvonen J; Peltonen L
Int J Pharm; 2020 Sep; 587():119636. PubMed ID: 32659405
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
[TBL] [Abstract][Full Text] [Related]
51. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
52. Physicochemical characterization of papain entrapped in ionotropically cross-linked kappa-carrageenan gel beads for stability improvement using Doehlert shell design.
Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
J Pharm Sci; 2006 Sep; 95(9):1994-2013. PubMed ID: 16850431
[TBL] [Abstract][Full Text] [Related]
53. Nanosizing of poorly water soluble compounds using rotation/revolution mixer.
Takatsuka T; Endo T; Jianguo Y; Yuminoki K; Hashimoto N
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1061-7. PubMed ID: 19801859
[TBL] [Abstract][Full Text] [Related]
54. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
55. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
56. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
[TBL] [Abstract][Full Text] [Related]
57. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.
Zuo W; Qu W; Li N; Yu R; Hou Y; Liu Y; Gou G; Yang J
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1513-1522. PubMed ID: 28906144
[TBL] [Abstract][Full Text] [Related]
58. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
59. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles.
Basa S; Muniyappan T; Karatgi P; Prabhu R; Pillai R
Drug Dev Ind Pharm; 2008 Nov; 34(11):1209-18. PubMed ID: 18720147
[TBL] [Abstract][Full Text] [Related]
60. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]